Have we become so enamored with access — to influence, wealth, power — that we neglected the very old Jewish instinct that is ...

For over a century, its wines have captured the essence of terroir through bold Malbecs, elegant Chardonnays, and sparkling ...

The executive, who brought Novo’s first weight-loss shot to market, had to spend part of the meeting explaining why proposed ...

Total revenues of $753,000 for third quarter, and $1,571,000 for first nine months of 2025, from sales and collaborative research agreement - - Major advances in pipeline as Humacyte moves closer to ...

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...

Pfizer's stock is poised for recovery, driven by recent corporate news and a three-year reprieve on drug-import tariffs from the Trump administration, strengthening the bullish case despite prior ...

Shares of the pharmaceutical giant have been in the red for three consecutive years. It just reached a deal with the White House that will give it a three-year grace period on tariffs. Acquisitions ...

Pfizer is a large drugmaker with a strong history of working through difficult periods. The pharmaceutical giant's challenges include facing down an impending patent cliff. Pfizer's dividend payout ...

WASHINGTON (AP) — Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar ...

Pfizer struck a deal with the Trump administration to lower its U.S. medicine prices and invest an additional $70 billion in onshore manufacturing in exchange for shelter from tariffs. Pfizer on ...